
That’s very important, because with increasing strain on health services all over the world, the idea that early detection can reduce financial and capacity pressure is critical.ĬK: Where is Cognetivity’s technology currently in use? Can you talk about its applications outside of memory care?

Healthcare systems benefit hugely from early detection because it greatly reduces the lifetime cost of care for patients. Obviously that has great benefits to the patient, but also for payers. If you improve them, you massively improve the prospects for your brain health.

These are known as modifiable risk factors. Things like sleeping better, stopping drinking and smoking, better diet and exercise. If you learn about it early, before becoming severely or even moderately impaired, you can prolong your functional life for considerable amounts of time. Even in the absence of a disease-modifying therapeutic in the UK, although one has now been approved in the US and UAE, early detection makes a huge difference because there are many things you can do. TS: It’s extremely important to detect early. Now our challenge is to get it out there and make it available to as many people as possible.ĬK: Why is early intervention so important when it comes to conditions like dementia? The software detects subtle impairments in information processing speed to try and catch formative signs of the disease before it starts to have a significant impact on a patient’s life. Users are shown a series of natural images and must classify them as being either animal or non-animal pictures. The test from Cognetivity is an image categorisation test designed to engage specific areas of the brain affected in pre-symptomatic stages of cognitive decline.

Many patients may not notice any changes at all, but this window is a crucial one wherein interventions can be especially effective in prolonging a patient’s cognitive function. Mild cognitive impairment can emerge long before any significant symptoms of dementia. Through either its iPhone app OptiMind or CognICA, a tool designed explicitly for use in medical settings in conjunction with a care team, patients can use Cognetivity’s test to detect the presence of even a mild cognitive impairment. Would you take a test that could predict the potential onset of dementia? An artificial intelligence (AI) tool from Cognetivity Neurosciences is allowing patients to do just that.
